1. Home
  2. CALC vs LSTA Comparison

CALC vs LSTA Comparison

Compare CALC & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • LSTA
  • Stock Information
  • Founded
  • CALC 2011
  • LSTA 1980
  • Country
  • CALC United States
  • LSTA United States
  • Employees
  • CALC N/A
  • LSTA N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • CALC Health Care
  • LSTA Health Care
  • Exchange
  • CALC Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • CALC 36.0M
  • LSTA 31.2M
  • IPO Year
  • CALC N/A
  • LSTA N/A
  • Fundamental
  • Price
  • CALC $2.51
  • LSTA $2.51
  • Analyst Decision
  • CALC Strong Buy
  • LSTA Strong Buy
  • Analyst Count
  • CALC 5
  • LSTA 1
  • Target Price
  • CALC $18.20
  • LSTA $15.00
  • AVG Volume (30 Days)
  • CALC 32.4K
  • LSTA 58.9K
  • Earning Date
  • CALC 03-27-2025
  • LSTA 02-27-2025
  • Dividend Yield
  • CALC N/A
  • LSTA N/A
  • EPS Growth
  • CALC N/A
  • LSTA N/A
  • EPS
  • CALC N/A
  • LSTA N/A
  • Revenue
  • CALC N/A
  • LSTA N/A
  • Revenue This Year
  • CALC N/A
  • LSTA N/A
  • Revenue Next Year
  • CALC N/A
  • LSTA N/A
  • P/E Ratio
  • CALC N/A
  • LSTA N/A
  • Revenue Growth
  • CALC N/A
  • LSTA N/A
  • 52 Week Low
  • CALC $2.05
  • LSTA $2.19
  • 52 Week High
  • CALC $6.27
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • CALC 39.62
  • LSTA 40.33
  • Support Level
  • CALC $2.37
  • LSTA $2.51
  • Resistance Level
  • CALC $2.75
  • LSTA $2.66
  • Average True Range (ATR)
  • CALC 0.22
  • LSTA 0.19
  • MACD
  • CALC 0.00
  • LSTA -0.01
  • Stochastic Oscillator
  • CALC 26.17
  • LSTA 17.50

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Share on Social Networks: